Chinese expert consensus on extent of standardized lymphadenectomy for locally advanced gastric cancer (2022 edition).
10.3760/cma.j.cn441530-20220322-00111
- Collective Name:Gastric Cancer Association, China Anti Cancer Association
- Publication Type:Journal Article
- Keywords:
Expert consensus;
Lymph node dissection;
Radical gastrectomy;
Stomach neoplasms
- MeSH:
Consensus;
Gastrectomy;
Humans;
Lymph Node Excision;
Neoplasms, Second Primary/surgery*;
Prognosis;
Stomach Neoplasms/pathology*
- From:
Chinese Journal of Gastrointestinal Surgery
2022;25(4):277-283
- CountryChina
- Language:Chinese
-
Abstract:
Currently, surgery-based comprehensive therapy plays an important role in the treatment of local advanced gastric cancer (LAGC), and standard lymph node dissection is a mainstay of gastric surgery. Radical gastrectomy with D2 lymph node dissection is widely accepted based on the international publications of randomized clinical trials, but the extent of lymph node dissection is controversial. An adequate lymph node dissection may improve prognosis and reduce complications, and D2+ lymphadenectomy may improve surgical outcomes in some selected patients. To improve the efficacy of LAGC therapies, the Gastric Cancer Association, China Anti Cancer Association took the lead and organized experts to discuss and vote, and finally formulated this expert consensus. It is hoped that this consensus can provide reference for clinicians and further improve the diagnosis and treatment level of LAGC in China.
